Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of theTCF7L2rs7903146 risk T allele

rs12255372 Variant of TCF7L2 Gene Is Protective for Obesity in Mexican Children

(2011) Miguel Klünder-Klünder et al.   ARCHIVES OF MEDICAL RESEARCH

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

(2011) J. J. Holst et al.   DIABETES CARE

Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test

(2010) A. P. Gjesing et al.   DIABETOLOGIA

The disposition index: adjustment for peripheralvs.hepatic insulin sensitivity?

(2010) K. Faerch et al.   JOURNAL OF PHYSIOLOGY-LONDON

TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action

(2009) D. T. Villareal et al.   DIABETES

The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men

(2009) K. Pilgaard et al.   DIABETOLOGIA

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action

(2008) K. Færch et al.   DIABETOLOGIA

Impact ofTCF7L2rs7903146 on Insulin Secretion and Action in Young and Elderly Danish Twins

(2008) Lise Wegner et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM